For years, keratoconus treatment has been unpredictable—and CorneaGen’s Corneal Tissue Addition Keratoplasty (CTAK) may change that. In this video, Dr. James Landreneau (United States) discusses how this innovative surgical technique lets him reshape the cornea with precision and control—leading to more consistent outcomes and faster recovery in corneal treatment. CorneaGen CEO Mr. Bernie Iliakis (United States) adds perspective on CTAK’s unique shelf life and ability to maximize every cornea donation. Watch now to learn all about it!
Learn more at https://corneagen.com/.
Editor’s Note: This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
